Form 4: BioLife Solutions CMO Sells Shares for Tax Obligations
Insider Transaction Report
BioLife Solutions' Chief Marketing Officer, Todd Berard, sold 358 shares of common stock at $25.13 per share to cover tax withholding obligations related to restricted stock vesting.
Summary
- Todd Berard, Chief Marketing Officer of BioLife Solutions Inc. (BLFS), reported a sale of common stock.
- The transaction involved 358 shares disposed of at a price of $25.13 per share.
- The sale was executed on December 9, 2025.
- This transaction was conducted under a Rule 10b5-1(c) trading plan, which became effective on March 8, 2024.
- The primary purpose of the sale was to satisfy tax withholding obligations associated with the vesting of restricted stock.
- Following this transaction, Todd Berard directly owns 132,908 shares of BioLife Solutions common stock.
Sentiment
Score: 5
Explanation: The transaction is a routine, pre-planned sale for tax purposes, not indicative of positive or negative sentiment towards the company's future performance or a change in the insider's investment outlook.
Future Outlook
This filing does not contain any forward-looking statements or guidance, as it reports a past insider transaction.
Industry Context
This insider transaction is specific to BioLife Solutions and its Chief Marketing Officer, Todd Berard, and does not directly relate to broader industry trends or competitor activities beyond being a routine executive compensation event.
Stakeholder Impact
- Shareholders: A minor reduction in insider ownership, but for a routine tax purpose, which typically has minimal impact on investor sentiment or share price.
Key Dates
| Date | Description |
|---|---|
| 03-08-2024 | Effective date of the Rule 10b5-1(c) trading plan adopted by Todd Berard. |
| 12/09/2025 | Date of the reported transaction where 358 shares of common stock were sold. |
| 12/17/2025 | Date the Form 4 filing was signed by Todd Berard. |
Recommendation
holdThe transaction is a routine, pre-planned sale by an insider to cover tax obligations from restricted stock vesting. It does not reflect a change in the insider's view of the company's prospects and therefore does not warrant a change in investment recommendation based solely on this filing.
Keywords
BioLife Solutions, BLFS, Todd Berard, Form 4, Insider Transaction, Stock Sale, Tax Withholding, Restricted Stock, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.